Nyheder

Phase 3 Victory for First Individualized mRNA Cancer Vaccine: What Solutions Are Needed for the New Era of mRNA Therapeutics?

Phase 3 Victory for First Individualized mRNA Cancer Vaccine: What Solutions Are Needed for the New Era of mRNA Therapeutics?

On August 19, 2026, monumental news capable of entering the annals of oncology history arrived: Moderna and Merck jointly announced that the Phase ...
Phase 3 Victory for First Individualized mRNA Cancer Vaccine: What Solutions Are Needed for the New Era of mRNA Therapeutics?

Phase 3 Victory for First Individualized mRNA Cancer Vaccine: What Solutions Are Needed for the New Era of mRNA Therapeutics?

On August 19, 2026, monumental news capable of entering the annals of oncology history arrived: Moderna and Merck jointly announced that the Phase ...
Cancer Cell (IF 44.5) | Tumor Cells Resist Immune Checkpoint Therapy via Macrophage Efferocytosis-Mediated Fatty Acid Recycling

Cancer Cell (IF 44.5) | Tumor Cells Resist Immune Checkpoint Therapy via Macrophage Efferocytosis-Mediated Fatty Acid Recycling

Source: Liang Z, Long X, Wong PP, et al. Tumor cells metabolically resist immune-checkpoint therapy by macrophage efferocytosis-mediated fatty acid...
From Research to Regulatory Practice: Advancing NAT-Based Mycoplasma Testing for Biologics

From Research to Regulatory Practice: Advancing NAT-Based Mycoplasma Testing for Biologics

Mycoplasma contamination remains one of the most persistent safety concerns throughout biologics manufacturing—from cell banking and viral vector ...
Fast, Accurate, and Reliable Molecular Diagnostic Solutions for Nipah Virus Surveillance

Fast, Accurate, and Reliable Molecular Diagnostic Solutions for Nipah Virus Surveillance

Urgent Alert: Nipah Virus Outbreak in India A recent Nipah virus (NiV) outbreak in West Bengal, India has triggered emergency public health resp...
Exciting News! Yeasen’s GMP-Grade UltraAAV PEI Transfection Reagent Achieves FDA DMF Registration

Exciting News! Yeasen’s GMP-Grade UltraAAV PEI Transfection Reagent Achieves FDA DMF Registration

Yeasen Biotechnology has officially received confirmation from the U.S. Food and Drug Administration (FDA): our UltraAAV PEI Transfection Reagent–G...
Synthesis of siRNA and the Role of T4 RNA Ligase 2

Synthesis of siRNA and the Role of T4 RNA Ligase 2

Small interfering RNA (siRNA) is a powerful tool in molecular biology, widely used for gene silencing through RNA interference (RNAi). These short,...
Yeasen Groundbreaking Milestone in High Temperature Bst DNA Polymerase Evolution for Eliminating False Positive Issues in LAMP Assays

Yeasen Groundbreaking Milestone in High Temperature Bst DNA Polymerase Evolution for Eliminating False Positive Issues in LAMP Assays

Published in ACS Catalysis Loop-mediated isothermal amplification (LAMP) is a powerful DNA amplification technique celebrated for its simplicity...
mRNA Technology Breakthrough: Yeasen Reveals the Low-Toxicity and High Translation Secret of T7 RNA Polymerase Mutants

MRNA-teknologi Gennembrud: Yeasen afslører lavtoksiciteten og høj translationshemmelighed for T7 RNA-polymerase-mutanter

Konstrueret enzym reducerer skadelig dsRNA, baner vejen for sikrere mRNA-terapi Forskere fra Yeasen Biotechnology og dets datterselskab Molefutu...
Integrated Nucleic Acid Removal System for Producing UltraClean Low DNA Molecular Enzymes Solutions to Eliminate False Positives

Integreret nukleinsyrefjernelsessystem til produktion af ultra-rent lavt DNA-molekylær enzymer

Nukleinsyrekontamination har længe været en væsentlig hindring i udviklingen af ​​molekylær diagnostiske teknologier. Efterhånden som mere følsomme...
Congratulations! Ucello’s Cord Blood-Derived Allogeneic Universal CAR-T Approved by US FDA IND!

Tillykke! Ucello's Cord Blood-afledte allogene universelle bil-T godkendt af US FDA Ind!

Ucello Biotechnology Co., Ltd., en vigtig strategisk partner for Yeasen Bioteknologi, har uafhængigt udviklet en CD19-målrettet kimær antigenrecept...
Development of T7 RNA polymerase (low dsRNA) with lower terminal transferase and RDRP activities through FADS and semi-rational design.

Udvikling af T7 RNA-polymerase (lavt dsRNA) med lavere terminal transferase og RDRP-aktiviteter gennem FAD'er og semi-rationelle design.

I de senere år har mRNA-baserede lægemidler fået betydelig opmærksomhed og tiltrukket forskningsfokus. T7 RNAP er kendt for sin enkelhed og evne ti...
Sharing the Validation Report of the Double-stranded RNA (dsRNA) ELISA Kit to Promote the Standardization of dsRNA Detection.

Deling af valideringsrapporten for det dobbeltstrengede RNA (dsRNA) ELISA-kit for at fremme standardiseringen af ​​dsRNA-detektion.

Leder du efter en pålidelig måde at detektere resterende dsRNA under mRNA in vitro transkription? Se ikke længere end det dobbeltstrengede RNA (dsR...
Achieving Proficiency in Host Cell Protein Detection Methods: Exploring Commercialization versus Customization

Opnåelse af færdigheder i detektionsmetoder til værtscelleprotein: Undersøgelse af kommercialisering versus tilpasning

Yeasen Biotechnologys kommercielle HCP-reagenssæt er en enkel, meget følsom og objektiv metode til HCP-detektion. Yeasen Biotechnology har uafhængi...

Forespørgsel